greeksoup/ stock research

Dentsply Sirona (XRAY) FY2014 results: revenue $2.9 billion, down 1.0% on the year

Dentsply Sirona Inc. (XRAY) reported revenue of $2.9 billion for fiscal 2014, the year ended 31 December 2014, down 1.0% on the year before. Net income was $323 million, up 3.1%, and diluted earnings per share $2.24. The figures are the company's own, from the 10-K it filed with the SEC on 20 February 2015.

Revenue
$2.9 billion
-1.0% on the year
FY2007FY2014
Operating margin
15.2%
14.2% a year earlier
FY2007FY2014
Net income
$323 million
+3.1% on the year
FY2007FY2014
Diluted EPS
$2.24
+3.7% on the year
FY2007FY2014

this yearthe year beforeHover a bar for its figure.

The year in brief

Income statement (profit and loss)

$ millionFY2014FY2013FY2012On the yearLast 8 years
Revenue2,9232,9512,928-1.0%
Cost of revenue1,3231,3731,372-3.7%
Gross profit1,6001,5771,556+1.4%
Gross margin54.7%53.5%53.1%
Research and development80.885.185.4-5.1%
Selling, general and administrative1,1431,1451,149-0.2%
Operating income446419382+6.3%
Operating margin15.2%14.2%13.0%
Interest expense46.949.656.9-5.5%
Pre-tax income404369331+9.5%
Income tax81.152.18.9+55.6%
Effective tax rate20.1%14.1%2.7%
Net income323313314+3.1%
Net margin11.0%10.6%10.7%
Diluted EPS$2.24$2.16$2.18+3.7%
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2014FY2013FY2012On the yearLast 8 years
Operating cash flow560418370+34.1%
Capital expenditure99.610092.1-0.8%
Free cash flow461318278+45.1%
Free cash flow margin15.8%10.8%9.5%
Cash from investing-139-260-115
Cash from financing-336-162-256
Depreciation and amortisation129128129+0.9%
Share-based compensation25.425.122.2+1.3%
Buybacks16311838.8+38.3%
Dividends paid37.334.831.4+7.2%
Dividend per share$0.27$0.25$0.22+6.0%
Diluted shares, weighted144m145m144m-0.5%
Shares outstanding at period end141m142m142m-0.9%

Balance sheet

$ millionFY2014FY2013FY2012On the yearLast 8 years
Shareholders' equity2,3212,5352,209-8.4%
Non-controlling interest0.942.940.7-97.9%
Debt1,2631,4761,521-14.5%
Other liabilities1,0651,0241,202+4.0%
Total liabilities and equity4,6505,0784,972-8.4%
Fixed assets589637615-7.6%
Goodwill2,0892,2822,211-8.4%
Intangible assets671795831-15.7%
Cash and equivalents15275.080.1+102.3%
Inventory387439403-11.7%
Other assets763850833-10.3%
Total assets4,6505,0784,972-8.4%

10-K for the year ended 31 December 2014, filed 20 February 2015: the filing.